===
EQS Voting Rights Announcement: SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act]
with the objective of Europe-wide distribution
2024-06-24 / 17:00 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings
1. Details of issuer
Name: SCHOTT Pharma AG & Co. KGaA
Street: Hattenbergstraße 10
Postal code: 55122
City: Mainz
Germany
Legal Entity Identifier (LEI): 529900TU48UE99NHEY88
2. Reason for notification
X Acquisition/disposal of shares with voting rights
X Acquisition/disposal of instruments
Change of breakdown of voting rights
Other reason:
3. Details of person subject to the notification obligation
Legal entity: The Capital Group Companies, Inc.
City of registered office, country: Los Angeles, United States of America (USA)
4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.
SMALLCAP World Fund, Inc.
5. Date on which threshold was crossed or reached:
20 Jun 2024
6. Total positions
% of voting rights % of voting rights through Total of
attached to shares instruments both in % Total number of voting rights
(total of 7.a.) (total of 7.b.1 + 7.b.2) (7.a. + pursuant to Sec. 41 WpHG
7.b.)
New 3.01 % 0.29 % 3.31 % 150614616
Previous 2.96 % 0.34 % 3.30 % /
notification
7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
Direct Indirect Direct Indirect
(Sec. 33 WpHG) (Sec. 34 WpHG) (Sec. 33 WpHG) (Sec. 34 WpHG)
DE000A3ENQ51 0 4539746 0 % 3.01 %
Total 4539746 3.01 %
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion Voting rights absolute Voting rights in %
period
0 0 %
Total 0 0.00 %
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or Exercise or Cash or physical Voting rights Voting
maturity date conversion period settlement absolute rights in %
Rights to recall lent shares Physical 442088 0.29 %
of Common Stock settlement
Total 442088 0.29 %
8. Information in relation to the person subject to the notification obligation
Person subject to the notification obligation is not controlled nor does it control any other
undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal
entity:
Name % of voting rights (if at % of voting rights through instruments Total of both (if at
least 3% or more) (if at least 5% or more) least 5% or more)
The Capital Group % % %
Companies, Inc.
Capital Research and 3.01 % % %
Management Company
- % % %
9. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %
10. Other explanatory remarks:
Date
21 Jun 2024
===
-----------------------------------------------------------------------------------------------------------------------
2024-06-24 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com
-----------------------------------------------------------------------------------------------------------------------
===
Language: English
Company: SCHOTT Pharma AG & Co. KGaA
Hattenbergstraße 10
55122 Mainz
Germany
End of News EQS News Service
===
1931927 2024-06-24 CET/CEST
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1931927&application_name=news
END) Dow Jones Newswires
June 24, 2024 11:00 ET (15:00 GMT)